Evidence map›Paper›PMID 15790531›Full record

ReviewBrain research. Molecular brain research2005

Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease.

Manuchair Ebadi, Holly Brown-Borg, Hesham El Refaey, Brij B Singh, Scott Garrett, Shaik Shavali, Sushil K Sharma

Open access · greenAbstract readReview
In one paragraph

Review in Brain research. Molecular brain research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Oxidation Driven Reversal of PIPFunction (Oxford, England) · 2023
    Article
  5. Article
  6. Article
  7. Mouse models of growth hormone deficiency.Reviews in endocrine & metabolic disorders · 2021
    Review
  8. Article
  9. Article
  10. Review
  11. Mass Spectrometry in Advancement of Redox Precision Medicine.Advances in experimental medicine and biology · 2019
    Review
  12. Metallothionein in Brain Disorders.Oxidative medicine and cellular longevity · 2017
    Review
  13. Review
  14. The MPTP Story.Journal of Parkinson's disease · 2017
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Manuchair EbadiDepartment of Pharmacology, Physiology, and Therapeutics, University of North Dakota, 501 North Columbia Road, Grand Forks, ND 58203, USA. mebadi@medicine.nodak.edu
Holly Brown-Borg
Hesham El Refaey
Brij B Singh
Scott Garrett
Shaik Shavali
Sushil K Sharma
University of North Dakota · US

Funding

TRPC1, Calcium, and Saliva SecretionR01DE017102 · NIDCR · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Brij B Singh · 2006 to 2026
$7.5M
UBIQUINONE AND MITOCHONDRIAL OXIDATIVE DISORDERS OF AGINR01AG017059 · NIA · UNIVERSITY OF NORTH DAKOTA · PI EBADI, MANUCHAIR · 1999 to 2003
$1.3M
INDUCTION AND EXPRESSION OF BRAIN METALLOTHIONEINR01NS034566 · NINDS · UNIVERSITY OF NORTH DAKOTA · PI EBADI, MANUCHAIR · 1995 to 2001
$376k
NIA NIH HHS R01 AG017059NIA NIH HHS R01 AG17059-09NIDCR NIH HHS R01 DE017102NINDS NIH HHS 2R01 NS3456609
6 · The paper itself

Abstract

Parkinson's disease is characterized by a progressive loss of dopaminergic neurons in the substantia nigra zona compacta, and in other sub-cortical nuclei associated with a widespread occurrence of Lewy bodies. The cause of cell death in Parkinson's disease is still poorly understood, but a defect in mitochondrial oxidative phosphorylation and enhanced oxidative and nitrative stresses have been proposed. We have studied control(wt) (C57B1/6), metallothionein transgenic (MTtrans), metallothionein double gene knock (MTdko), alpha-synuclein knock out (alpha-syn(ko)), alpha-synuclein-metallothionein triple knock out (alpha-syn-MTtko), weaver mutant (wv/wv) mice, and Ames dwarf mice to examine the role of peroxynitrite in the etiopathogenesis of Parkinson's disease and aging. Although MTdko mice were genetically susceptible to 1, methyl, 4-phenyl, 1,2,3,6-tetrahydropyridine (MPTP) Parkinsonism, they did not exhibit any overt clinical symptoms of neurodegeneration and gross neuropathological changes as observed in wv/wv mice. Progressive neurodegenerative changes were associated with typical Parkinsonism in wv/wv mice. Neurodegenerative changes in wv/wv mice were observed primarily in the striatum, hippocampus and cerebellum. Various hallmarks of apoptosis including caspase-3, TNFalpha, NFkappaB, metallothioneins (MT-1, 2) and complex-1 nitration were increased; whereas glutathione, complex-1, ATP, and Ser(40)-phosphorylation of tyrosine hydroxylase, and striatal 18F-DOPA uptake were reduced in wv/wv mice as compared to other experimental genotypes. Striatal neurons of wv/wv mice exhibited age-dependent increase in dense cored intra-neuronal inclusions, cellular aggregation, proto-oncogenes (c-fos, c-jun, caspase-3, and GAPDH) induction, inter-nucleosomal DNA fragmentation, and neuro-apoptosis. MTtrans and alpha-Syn(ko) mice were genetically resistant to MPTP-Parkinsonism and Ames dwarf mice possessed significantly higher concentrations of striatal coenzyme Q10 and metallothioneins (MT 1, 2) and lived almost 2.5 times longer as compared to control(wt) mice. A potent peroxynitrite ion generator, 3-morpholinosydnonimine (SIN-1)-induced apoptosis was significantly attenuated in MTtrans fetal stem cells. These data are interpreted to suggest that peroxynitrite ions are involved in the etiopathogenesis of Parkinson's disease, and metallothionein-mediated coenzyme Q10 synthesis may provide neuroprotection.

Indexed as

Disease Models, Animalalpha-SynucleinAnimalsApoptosisBrainCoenzymesDopamineGene Expression RegulationHumansMetallothioneinMiceMice, Neurologic MutantsMice, TransgenicMPTP PoisoningNerve Tissue ProteinsParkinson Diseasealpha-Synucleincoenzyme Q10CoenzymesDopamineMetallothioneinNerve Tissue ProteinsSNCA protein, humanSnca protein, mouseSynucleinsUbiquinone

Identifiers

PMID15790531
PMCPMC3619407
OpenAlexW2088664861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.